The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• Hyundai Sales Grow 9.5% During April 
• GE T&D Receives Order for Transmission Asset Management Centre in Odisha
• PB Fintech Plans to Acquire 100% Stake in Genesis Group
• Indus Towers Announced Q4 Earnings; Net Profit Rises 32%
• Indian Oil Announced Q4 Earnings; Net Profit Plunges 49% 

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.